HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population
ConclusionsOur prospective study performed in a real-world setting showed a high immunogenicity and safety of HBV-AS04 vaccine in patients with CKD not yet on maintenance dialysis. Studies provided with longer follow-ups are under way to assess the durability of seroprotection in responders.
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research
More News: Allergy & Immunology | Chronic Kidney Disease | Dialysis | Gastroenterology | Hepatitis | Hepatitis B | Hepatitis Vaccine | Study | Urology & Nephrology | Vaccines